Deutsches Referenzzentrum für Ethik in den Biowissenschaften (DRZE)

Titel: Stem Cells Advanced Course: "Stem Cells and therapeutic applications"

Termin: 15.10.2006, 18:30 Uhr, bis 19.10.2006, 21:00 Uhr

Veranstaltungsort:
Mercure Coudray Montceaux
Route de Milly
91830 Le Coudray Montceaux

Referenten: Ali Turhan (Poitiers University Teaching Hospital (CHU), France) *** Anne-Lise Bennaceur-Griscelli (Paul Brousse Hospital, France) *** Carine Camby (French Biomedicine Agency, France) *** Christian Jorgensen (INSERM, France) *** Frank Barry (National University of Ireland) *** Gerhard Gross (German Research Centre for Biotechnology, Germany) *** Glyn Stacey (UK Stem Cell Bank, NIBSC, United Kingdom) *** Jean Paul Renard (National Institute for Agricultural Research (Inra), France) *** Laure Coulombel (Paul Brousse Hospital, France) *** Majid Mehtali (Vivalis Company, France) *** Marc Peschanski (INSERM, France) *** Michel Puceat (Research Center of Macromolecular Biochemistry, France) *** Nissim Benvenisty (Jerusalem, Israel) *** Philippe Menasché (Hospital European Georges Pompidou, France) *** Rocky Tuan (NIH, USA) *** Tsvee Lapidot (Weizmann Institute of Science, Israel) *** Yann Barrandon (Lausanne, Switzerland)

Weitere Informationen:
http://www.genopole.fr/stemcells-course/

Kurzbeschreibung: Genopole Evry (near Paris) is one of the largest genomic research and biotechnology parks in France

From October 16th to 19th, 2006, Genopole is organising an Advanced Course dedicated to “Stem Cells and therapeutic applications”. This course is most particularly addressed to post-doctoral and senior scientists who wish to enter the field of stem cell research or else to extend their research to new domains in the stem cell field, whatever the type of cells and the goal they envision pursuing.

Since the audience will be limited to 40 participants a selection will be carried out by the Scientific Committee.

Stem cells, whether embryonic –immortal and pluripotent- or tissue-specific –with less proliferative power and only multipotent- are either already used or else deemed quite promising for therapeutics in a vast number of pathologies. They may in particular be employed to build up cell banks from which “therapeutic cells”, amplified and differentiated on demand, could be prepared to fulfil the logistic needs of transfer of biological products (cell and gene therapy). Stem cells may also permit to model healthy or diseased human tissues and organs, thus providing powerful and flexible tools with which to screen molecules for predictive toxicology or therapeutic efficacy. A wealth of studies have already been dedicated to the biology of some stem cell populations, and the knowledge gathered can be quite extensive, e.g. on the haematopoietic system or the skin. Nevertheless, major mechanisms remain largely elusive, including those that support the two characterizing attributes of all stem cells, i.e. the capacity for self-renewal, on the one hand, for differentiation into tissue-specific cells, on the other hand.

The program of the course has been set in order to provide participants with the most up-to-date view of all main issues of interest for stem cell research, as identified and presented by sixteen world renown speakers.

Kontakt: Mrs Chatherine Meignen
GENOPOLE®
2, rue Gaston Crémieux, BP 5723
91057 Evry cedex
FRANCE
Tel.: +33 - (0)1 - 60 87 83 02
Fax: +33 - (0)1 - 60 87 35 00
catherine.meignen@genopole.fr
http://www.genopole.fr/

Veranstalter: GENOPOLE®

Schlagworte: Embryonale Stammzellen, Klonierung

Artikelaktionen